Literature DB >> 3157437

Synergistic anti-suppressor effect of mini cells prepared from Salmonella typhimurium and mitomycin C in EL 4-bearing mice.

S Kurashige, Y Akuzawa, S Mitsuhashi.   

Abstract

The subcutaneous growth of EL4 cells was significantly accelerated when they were injected together with spleen cells collected from mice which had received EL4 cells SC 14 days previously, and all mice died within 18 days after receiving this mixture; 80% of mice which received a mixture of EL4 and spleen cells collected immediately after EL4 graft survived over 40 days. Spleen cells collected 14 days after EL4 graft suppressed the blastogenic responses of normal spleen lymphocytes to concanavalin A, pokeweed mitogen, and lipopolysaccharide of Escherichia coli in a mixed culture system. Acceleration of tumor growth was retarded when EL4 cells were injected together with spleen cells from EL4-bearing mice treated with both Salmonella typhimurium mini-cells and mitomycin C, and 60% of mice survived over 40 days. Blastogenic responses of normal spleen lymphocytes mixed with spleen cells from EL4-bearing mice treated with both mini-cells and mitomycin C were restored almost to control levels. The results suggest that combination treatment with mini-cells and mitomycin C synergistically inhibits the induction of suppressor cells in EL4-bearing mice.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3157437     DOI: 10.1007/bf00199720

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  14 in total

1.  Inhibitory effect of a streptococcal preparation (OK-432) on induction of splenomegaly by Friend leukemia virus.

Authors:  S Suzuki; A Yamamoto; H Ogawa
Journal:  Gan       Date:  1975-08

2.  Effect of Bacillus Calmette-Guerin infection on transplanted tumours in the mouse.

Authors:  L J OLD; D A CLARKE; B BENACERRAF
Journal:  Nature       Date:  1959-07-25       Impact factor: 49.962

3.  Cryptic plasmids in a minicell-producing strain of Salmonella typhimurium.

Authors:  R J Sheehy; D P Allison; R Curtiss
Journal:  J Bacteriol       Date:  1973-04       Impact factor: 3.490

4.  Active immunotherapy for acute lymphoblastic leukaemia.

Authors:  G Mathé; J L Amiel; L Schwarzenberg; M Schneider; A Cattan; J R Schlumberger; M Hayat; F De Vassal
Journal:  Lancet       Date:  1969-04-05       Impact factor: 79.321

5.  Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

6.  Effect of Corynebacterium parvum on tumor growth in normal and athymic (nude) mice.

Authors:  M F Woodruff; N L Warner
Journal:  J Natl Cancer Inst       Date:  1977-01       Impact factor: 13.506

7.  Enhancing effects of mini-cells prepared from Salmonella typhimurium on anti-tumor immunity in sarcoma 180-bearing mice.

Authors:  S Kurashige; S Mitsuhashi
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

8.  Immunopotentiating activity of whole cells and mini-cells of Salmonella typhimurium.

Authors:  S Kurashige; T Yoshida; K Kodama; S Mitsuhashi
Journal:  Microbiol Immunol       Date:  1981       Impact factor: 1.955

9.  Complications of BCG vaccination in neoplastic disease.

Authors:  C W Aungst; J E Sokal; B V Jager
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

10.  Depression of resistance against Salmonella infection in sarcoma 180-bearing mice and its restoration by Salmonella mini-cells.

Authors:  S Kurashige; Y Akuzawa
Journal:  Jpn J Exp Med       Date:  1984-06
View more
  2 in total

Review 1.  Recombinant Attenuated Salmonella enterica as a Delivery System of Heterologous Molecules in Cancer Therapy.

Authors:  Elayne Irene Becerra-Báez; Sergio Enrique Meza-Toledo; Paola Muñoz-López; Luis Fernando Flores-Martínez; Karla Fraga-Pérez; Kevin Jorge Magaño-Bocanegra; Uriel Juárez-Hernández; Armando Alfredo Mateos-Chávez; Rosendo Luria-Pérez
Journal:  Cancers (Basel)       Date:  2022-08-30       Impact factor: 6.575

Review 2.  Cancer Immunotherapy: Priming the Host Immune Response with Live Attenuated Salmonella enterica.

Authors:  Marco Antonio Hernández-Luna; Rosendo Luria-Pérez
Journal:  J Immunol Res       Date:  2018-09-13       Impact factor: 4.818

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.